Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Pharmaceuticals & Biotech
/
Merck KGaA
MRK
Merck KGaA
Aging Populations And Digitalization Will Unlock Life Sciences Potential
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
01 Jun 25
Updated
15 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€191.00
42.0% undervalued
intrinsic discount
15 Aug
€110.75
Loading
1Y
-34.8%
7D
2.5%
Author's Valuation
€191.0
42.0% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€191.0
42.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
24b
2014
2017
2020
2023
2025
2026
2028
Revenue €24.0b
Earnings €4.0b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.60%
Pharma revenue growth rate
0.58%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
4.76%
Calculation
€4.01b
Earnings '28
x
23.98x
PE Ratio '28
=
€96.18b
Market Cap '28
€96.18b
Market Cap '28
/
437.97m
No. shares '28
=
€219.60
Share Price '28
€219.60
Share Price '28
Discounted to 2025 @ 4.76% p.a.
=
€191.01
Fair Value '25